Clinical Trials Directory

Trials / Sponsors / Australian and New Zealand Urogenital and Prostate Cancer Trials Group

Australian and New Zealand Urogenital and Prostate Cancer Trials Group

Academic / Other · 9 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingWorking Out M0 Bipolar Androgen Therapy
Prostate Cancer
Phase 22024-08-14
TerminatedBiomarker-driven Intermittent Docetaxel in Metastatic Castration-resistant Prostate Cancer
Castration Resistant Prostatic Cancer
Phase 22022-07-29
UnknownEVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRP
Prostatic Neoplasms, Genital Neoplasms, Male, Urogenital Neoplasms
Phase 22022-04-29
UnknownEnzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate C
Metastatic Castration-Resistant Prostate Cancer
Phase 22020-08-17
CompletedANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)
Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Type 1, Papillary Renal Cell Carcinoma Type 2
Phase 22019-04-11
CompletedA Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostat
Cancer of the Prostate, Metastatic Cancer
Phase 22018-01-29
UnknownDenosumab and Pembrolizumab in Clear Cell Renal Carcinoma
Renal Cell Carcinoma, Clear Cell, Metastatic Kidney Cancer
Phase 22017-12-12
UnknownPhase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Meta
Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Type 1, Papillary Renal Cell Carcinoma Type 2
Phase 22017-10-19
CompletedPembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer
Bladder Cancer
Phase 22017-07-11